Adenosine-to-inosine RNA editing is crucial for generating molecular diversity, and serves to regulate protein function through recoding of genomic information. Here, we discover editing within Ca V 1.3 Ca 2+ channels, renown for low-voltage Ca
INTRODUCTION
Adenosine-to-inosine (A-to-I) RNA editing is a versatile posttranscriptional mechanism that allows pinpoint recoding of transcripts at the resolution of single nucleotides. This mechanism can drastically impact both the expression levels and functional properties of resulting proteins, thereby expanding the repertoire of protein customization (Keegan et al., 2001) . The underlying chemistry involves ADAR enzymes (adenosine deaminases acting on RNA) that catalyze the deamination of adenosine (A) to generate inosine (I) at certain nucleotide positions within RNA. Because inosine is decoded as guanosine (G) during translation, resulting protein products feature exquisitely customized amino acid composition. In the mammalian brain, characterization of such RNA editing has mainly focused on a restricted subset of ion channels and neurotransmitter receptors-editing of AMPA/kainate-type glutamate receptors (GluRs) yields changes in Ca 2+ permeability or agonist desensitization, while that of serotonin 2C receptors leads to altered G protein signaling (Burns et al., 1997; Seeburg et al., 1998) . Functionally, the adenosine deaminase enzyme ADAR2 is responsible for RNA editing that recodes a glutamine to arginine in the selectivity filter of GluR-B subunits (''Q/R editing'' of GluR-B); consequently, ADAR2 knockout mice exhibit increased Ca 2+ permeability, with concomitant epilepsy and death (Higuchi et al., 2000) . More broadly, a generalized dysregulation of brain RNA editing in humans may contribute to epilepsy, depression, and suicidal tendencies (Gurevich et al., 2002; Schmauss, 2003; Sergeeva et al., 2007) . Indeed, it is likely that numerous other editing substrates remain to be identified in the mammalian brain, given the high inosine content of mRNA in neural tissue (Paul and Bass, 1998) .
In particular, we wondered whether RNA editing might finetune the calmodulin (CaM) regulation of voltage-gated calcium channels (VGCCs). This Ca 2+ feedback regulation would be an especially attractive target for editing, because structure-function analysis reveals that even single amino acid substitutions at critical channel hotspots can markedly alter modulatory properties Tadross et al., 2008; Zü hlke et al., 2000) , and such regulation impacts functions as diverse as neurotransmitter release, neuronal pacemaking, neurite outgrowth, and gene expression (Dunlap, 2007) . Figure 1A cartoons such regulatory hotspots, which are located on the amino-and carboxyl-termini of the pore-forming a 1 subunits of VGCCs. The best-studied locus is a CaM-binding domain approximating a consensus IQ element satisfying the amino acid pattern IQxxxRGxxxR (Jurado et al., 1999) , with x denoting any residue. CaM binding at this IQ domain is critical for CaM/channel regulation (Liu et al., 2010) , and mutations in the central isoleucine strongly attenuate Ca 2+ regulation (Shen et al., 2006; Yang et al., 2006) .
Here, we reveal the existence of ADAR2-mediated RNA editing of the IQ domain of Ca V 1.3 channels. This editing appears specific to the central nervous system, and proteomic analyses indeed confirm the presence of edited Ca V 1.3 channel proteins within native brain tissues. Adding to the theme of specificity, no RNA editing was found for Ca V 1.3 coding regions outside of the IQ domain, nor was IQ-domain editing present in any other members of the Ca V 1-2 channel family. All these features suggest that Ca V 1.3 editing may entail distinctive sequelae for the CaM-dependent inactivation (CDI) of these channels, particularly in relation to the availability of these low-voltage activated channels to support neurotransmission at ribbon synapses (Evans and Zamponi, 2006; Yang et al., 2006) and repetitive firing within neurons throughout the brain (Chan et al., 2007) . Accordingly, we demonstrate that RNA editing of the Ca V 1.3 IQ domain can strongly diminish the CDI of these channels. Furthermore, as a first step toward evaluating the neurobiological impact of Ca V 1.3 IQ-domain editing, we characterized repetitive firing (A) Cartoon of Ca V 1.3 channel pore-forming a 1 subunit (a 1D ), with hotspots for CaM/channel regulation shown on the amino terminus (NSCaTE) , and in the CI region of the carboxyl terminus (EF, EF-hand) (Peterson et al., 2000) ; preIQ and IQ domains Pitt et al., 2001) . properties of neurons in the suprachiasmatic nucleus (SCN), an oscillatory brain region that contributes a central biological clock for circadian rhythms in mammals. Of particular relevance, SCN oscillations appear to be substantially driven by L-type Ca 2+ currents, most of which are carried by Ca V 1.3 channels (Marcantoni et al., 2010; Pennartz et al., 2002; Xu and Lipscombe, 2001 ). Importantly, we now find that RNA editing alters both CDI and the frequency of repetitive electrical activity, as judged by comparison of CDI and SCN rhythmicity in wild-type and transgenic mice wherein RNA editing was eliminated. Additionally, since the chemical compound Bay K 8644 selectively diminishes CDI and augments overall current amplitude in L-type Ca 2+ channels (Tadross et al., 2010) , we utilized this agent as a selective pharmacological mimic of altered Ca V 1.3 IQ domain editing. Indeed, the effects of Bay K 8644 on SCN rhythmicity were strikingly reminiscent of those produced upon transitioning from wildtype to transgenic mice lacking RNA editing. Accordingly, our experiments demonstrate that regulation of mammalian circadian rhythmicity constitutes one of potentially many important consequences of Ca V 1.3 RNA editing.
RESULTS
Detecting RNA Editing of the IQ Domain in Ca V 1.3 Channels A schematic of the pore-forming a 1 subunit of VGCCs, together with the main elements supporting CaM-mediated CDI, furnishes the structural context of our search for RNA editing ( Figure 1A ). The presence of an NSCaTE Ca 2+ /CaM binding site tunes the dynamic Ca 2+ sensitivity of CDI Tadross et al., 2008) , whereas PreIQ and IQ domains harbor functionally important binding sites for both apoCaM (Ca
2+
-free CaM) and Ca 2+ /CaM Liu et al., 2010; Pitt et al., 2001) . Ca
-driven movements of CaM among these various sites trigger CDI, with the collaboration of an EF-hand-like module that transduces CaM movements into altered channel gating (de Leon et al., 1995; Kim et al., 2004; Peterson et al., 2000) . Although the collective action of several modules produces CDI, even single mutations in some of these structural hotspots can severely modify CDI Peterson et al., 2000; Tadross et al., 2008; Zü hlke et al., 2000) . Nowhere is this single-residue alteration of CDI better known than in the IQ domain (Dunlap, 2007) , which thus serves as the focus of our screen.
At the genomic level, the predicted amino acid sequence at the core of the IQ domain is IQDY. These are coded by the nucleotides ATACAGGACTAC, as explicitly confirmed by PCR amplification and sequencing of the rat genomic DNA ( Figure 1B) . Also as expected, amplification of the corresponding Ca V 1.3 IQ domain in rat thalamic mRNA yielded a seemingly homogeneous PCR product of 300 bp ( Figure 1C, upper panel) . However, direct sequencing of this RT-PCR product showed obvious evidence of RNA sequence variability at two adenosine positions, characterized by conspicuous A/G double peaks in sequencing chromatograms ( Figure 1C , bottom half, arrows on green and gray bands). These double peaks indicated that in addition to the canonical IQDY sequence, alternative sequences like MQDY, IQDC, and MQDC could also be manifest at the protein level, as summarized in Figure 1C . To detect even rare occurrences of RNA sequence variability, we employed colony screening, where RT-PCR products were cloned into bacterial colonies, and sequencing performed on amplified DNA from individual colonies. This approach not only confirmed the two sites of variability above, but also revealed a rarer locus where CAG (Q) was modified to CGG (R), which encodes an IRDY sequence ( Figure 1C , bottom row). These instances of RNA sequence variability were consistent with RNA editing, and could produce the amino acid variations shown in Figure 1C . Yet further potential combinatorial variation of the IQ domain is detailed in Figure S1A available online.
In contrast to the ready detection of RNA sequence variability within the Ca V 1.3 IQ domain, further regions of editing were not observed. Transcript-scanning of the complete a 1D subunit from total rat brain RNA, using direct sequencing of RT-PCR products, gave no indication of sequence variability outside of the IQ module. Furthermore, analysis of total brain RNA for the paralogous IQ domains of other Ca V channels (Ca V 1.2, Ca V 1.4, Ca V 2.1, Ca V 2.2, and Ca V 2.3) also failed to reveal such variation ( Figure S1B ).
Outside of the central nervous system (CNS), Ca V 1.3 is functionally important in cochlea, heart (Platzer et al., 2000; Shen et al., 2006) , pancreas Safa et al., 2001; Taylor et al., 2005) , and other tissues. Yet, no RNA sequence variability at the Ca V 1.3 IQ domain was observed in rat cochlea, heart, pancreatic b-islet, and dorsal root ganglion cells ( Figure 1D ), despite ADAR2 expression in these contexts (Gan et al., 2006; Melcher et al., 1996) . Overall, CNS modulation of RNA sequence within the Ca V 1.3 IQ region appeared rather special.
Before turning to the mechanisms underlying this RNA sequence variability, we tested whether such variability produces veritable diversity at the protein level, using state-ofthe-art mass spectrometry. Ca V 1.3 complexes isolated from whole mouse brain were trypsinized, labeled with mTRAQ, and analyzed via HPLC-MS/MS multiple reaction monitoring (MRM, see Figure S2 for details). Signals for peptides containing FYATFLMR, FYATFLMRDYFR, KFYATFLIQDCFR, and KFYATFLIR isoforms of the IQ domain were detected, as well as that of the unedited IQ domain (FYATFLIQDYFR). BLAST analysis confirmed that the variant sequences are unique within the mouse genome. Hence, I-to-M, Q-to-R, and Y-to-C recoding of amino acids are present within the actual Ca V 1.3 protein.
ADAR2
Mediates Editing of the Ca V 1.3 IQ Domain With assurance of genuine IQ-domain alterations, we considered the mechanism supporting this variability, noting that RNA editing of adenosine to guanosine is believed to require enzymes belonging to a class known as adenosine deaminases acting on RNA (ADAR) (Keegan et al., 2001) . These ADARs bind to duplex stem-loop structures within pre-mRNA, and then catalyze deamination of adenosines to inosine (I) (Figure 2A ). This action effectively alters the codon within the mature edited mRNA, because inosine is decoded as guanosine by the translation machinery. To test whether the specific deaminase isoform ADAR2 is responsible for the Ca V 1.3 IQ domain variability, we compared results from wild-type GluR-B R/R mice to those of ADAR2 À/À /GluR-B R/R knockout animals (Higuchi Neuron RNA Editing of the IQ Domain in Ca v 1.3 Channels (Figure 2B, right) . Reassuringly, measurement of chromatogram areas yielded identical estimates of percent recoding ( Figure 2E ). Additionally, as an independent measure of percent recoding, a colony screening method produced a closely similar quantitative profile of sequence variability ( Figure 2B , right, darkercolored bars). The quantitative analyses revealed an overall rank order of RNA sequence variability (most frequent to rarest) of: ATA (I) recoding to ATG (M), followed at a slightly lower frequency by TAC (Y) recoding to TGC (C), followed much more rarely by CAG (Q) recoding to CGG (R). Another perspective came with extensive colony analysis of mouse whole brain, yielding an overall frequency distribution of IQ-domain sequence combinations ( Figure 2F ). Given this rich assortment of variants in wild-type mice, we undertook the key genetic experiment regarding the origin of this variability. Indeed, the ADAR2 knockout was devoid of sequence variability ( Figure 2C ), thus arguing strongly that ADAR2 is necessary for Ca V 1.3 IQ domain editing.
Spatio-Developmental RNA Editing in Rat and Mouse
Given the nuanced distribution of ADAR2 throughout the brain, we next explored the spatio-temporal occurrence of Ca V 1.3 RNA editing across the CNS. Accordingly, the editing analysis introduced in Figure 2B was applied to individual brain regions, such as frontal cortex, hippocampus, medulla oblongata, and cerebellum of rat brain. The analysis revealed that editing was spatially regulated across the rat brain, with frontal cortex and hippocampus showing the most editing ( Figures S3A and S3B ). These general trends from rat were recapitulated in the mouse brain ( Figure S3C ), with subtle intraspecies differences present at the quantitative level. As well, we explicitly confirmed the presence of Ca V 1.3 IQ domain editing in human brain ( Figure S4A ). Beyond spatial regulation, we also observed marked developmental modulation of IQ domain editing ( Figure 2D ). At embryonic day 14, the Ca V 1.3 IQ domain lacks detectable editing. By contrast, editing was observed as early as postnatal day 4, and reached adult levels by postnatal day 7. Similar trends were observed in both rats and mice, with bar-graph population summaries shown at the far right.
Selective Modulation of CDI by RNA Editing
With the existence and molecular basis of IQ-domain editing in hand, we investigated the critical question of functional impact on CaM-mediated CDI of Ca V 1.3 channels. Prior structurefunction work on Ca V 1.3 would suggest that RNA editing of the critical isoleucine-glutamine (IQ) di-peptide residues might well modulate this important Ca 2+ feedback system . To test for such an outcome, we performed electrophysiological analysis of recombinant Ca V 1.3 channels bearing the key IQ domain variants supported by RNA editing. As baseline, Figure 3A displays the wild-type Ca V 1.3 profile. Exemplar Ba 2+ currents (top panel, black trace), as evoked by maintained depolarization to near the peak of I-V relations, showed little decay, indicative of minimal voltage-dependent inactivation (VDI). By contrast, exemplar Ca 2+ currents evoked at the same potential showed a rapid decay (top panel, red trace), as produced by robust CaM-mediated CDI and Ca 2+ at À10mV. The difference between Ca 2+ and Ba 2+ relations then specifies CDI measured in isolation. The multi-second recovery from CDI is reported in the third panel by the fraction of peak current recovered after increasing durations at the holding potential (F recovery ). Finally, as for activation, the bottom two panels display the Ba 2+ tail-activation relation (G norm ), and the normalized peak Ba 2+ current versus voltage curve (I norm ). Compared to this reference behavior, Y-to-C editing of the IQ domain (e.g., IQDY recoding to IQDC) had little functional effect ( Figure S5A ). Beyond this, however, all other edited forms of Ca V 1.3 exhibited substantial alterations of CDI, with little change of either VDI or activation characteristics. Channels bearing the IQ-to-MQ variant of the IQ domain demonstrated a clearly weaker CDI ( Figure 3B , top two panels, wild-type: f = 0.72 ± 0.01; MQ: f = 0.45 ± 0.03), and perhaps a hint of faster recovery from inactivation. Wild-type profiles are reproduced as dashed curves, and the red shading emphasizes the effects of editing. The flat exemplar Ba 2+ current and r 50 relation ( Figure 3B , top two panels) demonstrates unchanged VDI, and steady-state inactivation (VDI) was also unperturbed in all IQ variants (Figure S5B) . Likewise, activation properties were essentially unchanged ( Figure 3B , bottom two panels). Channels with the IQ-to-IR variant of the IQ domain exhibited similar though weaker alteration of CDI ( Figure 3C , f = 0.60 ± 0.01), and closely similar recovery from inactivation as control. Most strikingly, the IQ-to-MR variant demonstrated pronounced effects-approximately 50% reduction in the onset of CDI ( Figure 3D , f = 0.33 ± 0.01), and sharply accelerated recovery from inactivation-both actions highly significant. To assess whether editing affects the ability of Ca V 1.3 channels to target to the neuronal surface membrane, we generated cDNAs encoding both unedited (IQDY) and various edited forms of Ca V 1.3 channels (MQDY, IRDY, MRDY or IQDC). These channels were also endowed with an extracellular HA tag to facilitate subsequent immunocytochemical assays of surface-membrane expression. As a preliminary check, electrophysiological characterization of heterologously expressed channels confirmed the absence of appreciable functional effects of the HA epitope itself ( Figure S5C ). We then transiently expressed the suite of HAtagged Ca V 1.3 clones in primary hippocampal neurons. Immunocytochemistry revealed similar surface expression patterns between the unedited and edited forms of Ca V 1.3 variants (Figure S5D) , arguing that transport of channels to the neuronal surface membrane was largely unaffected by editing. In addition, expression patterns of transfected Ca V 1.3 were similar to those of endogenous channels ( Figure S5D ).
Modification of SCN Rhythmicity in ADAR2 Knockout Mice
As a first step toward explicitly resolving the biological significance of RNA editing of the Ca V 1.3 IQ domain, we turned to neurons in the suprachiasmatic nucleus (SCN), where Ca V 1.3 currents figure prominently in triggering the spontaneous action potentials that underlie circadian rhythms (Pennartz et al., 2002) . Molecular analysis clearly confirmed RNA editing of the IQ domain in SCN ( Figure 4A ) (Higuchi et al., 2000) ; this feature is illustrated by the close similarity of blue-(wild-type) and cyan-colored (knock-out) Ba 2+ current waveforms ( Figure 4A 2 ), respectively averaged from wild-type (n = 7) and knockout (n = 6) neurons. Ca 2+ currents decayed with still greater rapidity (red trace, n = 6), just as expected without RNA editing of the Ca V 1.3 IQ domain. These trends were entirely corroborated by population analysis of multiple neurons ( Figure 4A 3 ) , particularly over the 0mV-10mV range where Ca V 1.3 channel CDI would likely predominate ( Figures S6A and S6B ). In this regard, despite the contribution of other Ca 2+ channel subtypes to overall current (Cloues and Sather, 2003) , most of the observed RNA-editing effects on CDI could be attributed to Ca V 1.3 channels, because little CDI was observed upon pharmacological blockade of Ca V 1.3 channels ( Figure S6C ), and a comparatively high level of intracellular Ca 2+ buffering was used (5 mM EGTA) to preferentially suppress Ca V 2 channel CDI Soong et al., 2002; Tadross et al., 2008) .
Having explicitly established effects of RNA editing on CDI within SCN neurons, we tested for potential corresponding consequences on SCN rhythmicity. Under current clamp of SCN neurons in acute slices of wild-type mice (GluR-B R/R ), we observed spontaneous discharges of sodium action potentials (''Na spikes'') characteristic of this preparation ( Figure 4B , top black). By contrast, SCN neurons of ADAR2 knockout mice (ADAR2 À/À /GluR-B R/R ) (Higuchi et al., 2000) exhibited Na spikes that fired at clearly lower frequencies ( Figure 4B , bottom red; and Figure 4D ), with a decreased depolarization rate preceding Na Figure 2A, (bottom, red) . In the knockout, Ca spike frequency is decreased, and troughs are depolarized. Red trace at extreme bottom shows abolition of Ca spikes by 10 mM nimodipine. Figure 4C ). This suite of effects in the ADAR2-deficient setting is consistent with a loss of RNA editing leading to increased Ca V 1.3 CDI, with corollary diminution of Ca V 1.3 pacemaking current. Two important controls warrant mention. First, the ''wild-type'' GluR-B R/R mice used as baseline were engineered for constitutive expression of the R-containing form of GluR-B subunits at the Q/R-editing site (Higuchi et al., 2000) ; hence, the alteration of Na spike activity seen upon transitioning to ADAR2 knockout animals ( Figures 4B-4D) could not have arisen trivially from a loss of Q/R editing of GluR-B subunits. Second, we determined that Q/R editing of GluR-B subunits in the SCN of non-engineered wild-type mice was complete ( Figure S4B ), thus excluding the possibility that engineering wild-type mice for constitutive expression of the R-form of GluR-B would, in itself, alter baseline excitability. Nonetheless, altering RNA editing of targets other than those considered thus far could still account for the rhythmicity effects up to this point. Accordingly, we analyzed the actions of ADAR2 elimination upon a persistent pattern of membrane potential oscillations that persists after application of a saturating concentration of TTX, as illustrated by the exemplar trace from a wildtype mouse ( Figure 4E , upper black trace). These repetitive ''Ca spikes'' feature a more readily defined role for L-type channels, because these spikes arise from a simpler system wherein oscillations are generated by recurring depolarization via L-type Ca 2+ current that in turn begets an ensuing phase of repolarization via Ca 2+ -activated K currents (Belle et al., 2009; Pennartz et al., 2002) . Importantly, while representing a simpler phenomenon, Ca spikes may closely reflect more integrated Na spike behavior (Pennartz et al., 2002) . Significantly, then, the specimen trace from an ADAR2-deficient mouse ( Figure 4E , middle red record) exhibits a reduced frequency of Ca spikes, concurrent with depolarization of troughs between spikes. Population averages from several SCN slices confirmed the attenuated Ca spike frequency upon ADAR2 elimination ( Figure 4G) ; and corresponding averages of time-aligned Ca spikes confirmed depolarization of troughs between Ca spikes ( Figure 4F ). Both effects of ADAR2 elimination accord well with heightened Ca V 1.3 CDI and resultant attenuation of Ca V 1.3 current. In particular, diminished low-threshold depolarizing current explains the decrement in Ca spike frequency, while reduced Ca 2+ entry during spikes would moderate Ca 2+ -activated K current and thereby repolarization between Ca spikes. Indeed, the role of Ca V 1.3 in driving Ca spikes was explicitly confirmed by abolishing spontaneous fluctuations with the L-type channel inhibitor nimodipine (Figure 4E , bottom red trace). In all, this spectrum of effects on the simpler system of Ca spikes hinted more strongly that RNA editing of Ca V 1.3 channels contributes to the altered SCN rhythmicity upon loss of ADAR2. Still, ADAR2-mediated editing of several other membrane currents involved in repetitive Ca spiking could explain even these results (Figures 4E-4G) . Accordingly, we investigated the actions of Bay K 8644, a highly-selective, L-type-channelspecific agonist. Although this compound has been available for some time, particularly relevant aspects of its actions have only recently become clear. Importantly, beyond its well-known ability to augment overall current, this compound also diminishes Ca
2+
-dependent inactivation (CDI), as demonstrated in our recent detailed biophysical analysis of Bay K 8644 actions on Ca V 1.3 (Tadross et al., 2010) . Given this functional profile, Bay K 8644 should act much like a selective pharmacological mimic of altered Ca V 1.3 IQ-domain editing. In particular, this compound should mirror the transition from an ADAR2 knockout context (more CDI and less current) to a wild-type context (less CDI with more current)-so long as RNA-editing-induced alteration of Ca spiking does arise from modified Ca V 1.3 CDI. Indeed, we observed a striking analogy between the effects of Bay K 8644 (Figures 4H-4J ) and those produced upon transitioning from knockout to wild-type mice (Figures 4E-4G) . Specifically, Bay K 8644 produced both an increase in overall Ca spike rate, and hyperpolarization of troughs between Ca spikes. More precisely, Bay K 8644 simulated an exaggerated wildtype phenotype, wherein reduction of CDI by RNA editing was enhanced beyond the normal wild-type level. It is possible that the effects of Bay K 8644 would be still stronger if applied to the knockout condition, since the initial level of CDI would be stronger. In all, these effects of Bay K 8644 on SCN Ca spikes, highly analogous to those in our transgenic experiments, argue well that RNA editing of Ca V 1.3 channels contributes to SCN rhythmicity.
Finally, to assess the overall quantitative sufficiency of editing-induced modifications of Ca V 1.3 CDI to modulate SCN rhythmicity, we undertook computational simulations of SCN pacemaking, utilizing refined versions of previously established models (Belle et al., 2009; Sim and Forger, 2007) . Here, we incorporated Ca V 1.3 profiles appropriate for our various experimental conditions (wild-type, ADAR2-deficient, and Bay K 8644 scenarios), and then observed the consequences for spontaneous activity (see Supplemental Information, section 6). Figure 5A displays the state-diagram for the Ca V 1.3 channel utilized in the refined models, along with corresponding CDI profiles for the differing conditions. Simulated Na spikes demonstrated a marked decrement in frequency upon transitioning from wildtype to ADAR2-deficient CDI configurations ( Figures 5B and  5D ). This decrement in frequency was accompanied by a decreased depolarization rate prior to Na spikes ( Figure 5C ), similar to effects observed experimentally ( Figure 4C ). Moreover, simulated Ca spikes demonstrated both decreased frequency and depolarization of troughs between spikes ( Figures 5E-5G ), qualitatively recapitulating experimental effects (Figures 4E-4G ). Finally, Bay K 8644 increased simulated Ca spike frequency and hyperpolarized troughs between Ca spikes ( Figures 5H-5J ), also as observed experimentally ( Figures 4H-4J ) Thus, projected alterations in Ca V 1.3 channel CDI by RNA editing were sufficient to explain a wide array of experimentally observed effects.
Taken together, the results in Figure 4 and Figure 5 suggest that RNA editing of the Ca V 1.3 IQ-domain modulates SCN firing rates and thereby the central biological clock underlying circadian rhythms. Beyond the SCN, we suspect that RNA editing of Ca V 1.3 channels will orchestrate further neurobiological effects, wherever these channels act to promote pacemaking and near-threshold activity. For example, robust RNA editing of Ca V 1.3 was also detected in rat substantia nigra ( Figure S4C ), where these channels contribute to pacemaking and heighten the onset of Parkinson's disease under pathological conditions (Chan et al., 2007) . Overall, RNA editing of the Ca V 1.3 IQ domain Neuron RNA Editing of the IQ Domain in Ca v 1.3 Channels could offer precise and potent tuning of neuronal activity in diverse brain regions.
DISCUSSION
Adenosine-to-inosine RNA editing posttranscriptionally recodes genomic information to generate molecular diversity. Many of the identified editing targets are found in the mammalian nervous system, with a historical focus on the family of GluR ion channels and serotonin 2C receptors (Schmauss, 2003; Seeburg and Hartner, 2003) . Beyond this focus, the list of editing targets is expanding. For example, outside of Ca V 1.3 channels, there are instances of Ca V channel editing exclusive of the IQ domain, though with uncertain biophysical consequences (Hoopengardner et al., 2003; Kawasaki et al., 2002; Keegan et al., 2005; Smith et al., 1998; Tsunemi et al., 2002) . In other voltage-gated channels, editing of K V 1.1/K V b1.1 channels speeds inactivation recovery (Bhalla et al., 2004) , and editing of insect Na + channels alters channel gating properties (Dong, 2007; Song et al., 2004) . Here, our discovery of editing within the Ca V 1.3 IQ domain represents a significant expansion to this group, given the robust functional modulation of Ca 2+ -dependent feedback control at this particular locus, and the broad range of biological roles served by these channels (Day et al., 2006; Sinnegger-Brauns et al., 2004; Striessnig et al., 2006) . Figure 6 schematically summarizes the general scope of RNA editing effects on Ca V 1.3 CDI, along with potential consequences for neuronal Ca 2+ load in neurons. Notably, ADAR2-mediated editing of Ca V 1.3 is exquisitely selective-editing of Ca V 1.3 is restricted to the IQ domain; IQ-domain editing is absent in other Ca V 1-2 channels; and Ca V 1.3 editing is restricted to the CNS. This selectivity suggests that editing of the Ca V 1.3 IQ domain may be critical for certain biological niches, where fine tuning of Ca 2+ feedback on channels (CDI) is especially desirable for low-voltage activated Ca where Ca V 1.3 currents modulate spontaneous action potentials underlying mammalian circadian rhythms (Pennartz et al., 2002 ). We clearly demonstrate that RNA editing substantially modulates SCN rhythmicity, a significant finding in its own right. More specifically, our data suggest that editing of Ca V 1.3 appreciably mediates this modulation. This suggestion merits two lines of discussion, given the multiplicity of potential editing targets in SCN.
First, the literature is rather divided regarding the role of L-type Ca 2+ channels in modulating SCN activity. While earlier studies (Pennartz et al., 2002 (Pennartz et al., , 1998 favor a substantial contribution of L-type Ca 2+ channels to SCN pacemaking, a more recent investigation emphasizes a more subsidiary influence of these channels (Jackson et al., 2004) . This seeming discrepancy may relate to differences of slice (Ikeda et al., 2003; Pennartz et al., 2002 Pennartz et al., , 1998 versus isolated neuron preparations of SCN (Jackson et al., 2004) . Fitting with this view, a similarly diminished role of voltage-gated Ca 2+ channels in shaping cerebellar pacemaking has been observed between slice (Womack et al., 2004) and isolated neuron experiments (Raman and Bean, 1999) . Indeed, our own experiments favoring an appreciable role of Ca V 1.3 were performed in the presumably more intact acute slice configuration. Second, as for differences in SCN rhythmicity observed between wild-type and ADAR2-deficient mice (Figure 4 ), our data argue well for the sufficiency of altered Ca V 1.3 CDI to contribute to these differences ( Figures 4H-4J and Figure 5) , and also exclude Q/R editing of GluR-B subunits as the causative mechanism ( Figure S4B ). Nonetheless, other potential editing targets remain to be considered. Could altered Q/R editing of kainate receptors modify SCN activity upon ADAR2 elimination (Herb et al., 1996) ? Countering this possibility, addition of kainate to wild-type SCN slices increased Ca spiking frequency while depolarizing troughs between spikes ( Figure S3D ), contradicting the outcome seen upon transitioning from ADAR2-deficient to wild-type contexts ( Figures 4E-4G ). Could editing of serotonin receptors explain our findings? Contrary to this view, it is the serotonin HT-7 receptor subtype that mediates serotonin effects in SCN (Aghajanian and Sanders-Bush, 2002; Lovenberg et al., 1993) , and there is no indication that HT-7 is edited like the HT-2C receptor subtype (Aghajanian and Sanders-Bush, 2002) . Could editing of GABA receptors contribute? GABA can certainly regulate SCN activity (Gillespie et al., 1997; Mintz et al., 2002) , and GABA receptors undergo RNA editing by ADAR2 (Ohlson et al., 2007) . Opposing this hypothesis, only the a 3 subunit of GABA A receptors is known to be edited (Ohlson et al., 2007) , and the a 3 subunit is only sparsely expressed in the adult mice relevant to our studies (O'Hara et al., 1995) . Finally, might editing of voltage-activated K + channels play a role? Against this position, only K V 1.1 channels are known to be RNA edited (Bhalla et al., 2004) , while SCN neurons have been reported to express K V 3.1 (Espinosa et al., 2008; Itri et al., 2005) , K V 3.2 (Itri et al., 2005) , K V 4.1 and K V 4.2 (Itri et al., 2010) . In fact, K V 1.1 knockout mice exhibit intact circadian rhythms, so long as overt seizure activity is controlled (Fenoglio-Simeone et al., 2009) . Overall, then, while comprehensive exclusion of alternative mechanisms is difficult to achieve, our data remain highly suggestive that RNA editing of Ca V 1.3 CDI influences SCN rhythmicity. Beyond the SCN, editing the Ca V 1.3 IQ domain is poised to modulate numerous other brain regions, wherever Ca V 1.3 contributes to low-voltage activated synaptic transmission and pacemaking (Day et al., 2006; Sinnegger-Brauns et al., 2004; Striessnig et al., 2006) . More broadly, developmental regulation of RNA editing of the Ca V 1.3 IQ domain ( Figure 2D ) could influence neurodevelopment via Ca 2+ -dependent transcription factors (S.P. Pasca et al., 2010, Soc. Neurosci., abstract, program no. 221.1; Wheeler et al., 2008; Zhang et al., 2006) . Furthermore, it would be interesting if Ca V 1.3 editing contributes to epilepsy, depression, and suicide affiliated with a generalized alterations of brain RNA editing (Gurevich et al., 2002; Schmauss, 2003; Sergeeva et al., 2007) . Investigating the role of edited Ca V 1.3 channels in these and other neurobiological processes now promise rich dividends for mechanistic advance and disease insight. agarose gel, isolated and purified using the QIAGEN gel extraction kit. The PCR product was sent for direct automated DNA sequencing (Applied Biosystems, Foster City, CA). Colony screening was performed by first subcloning PCR products into pGEM-T Easy vector (Promega, Madison, WI), transforming them into DH10B Escherichia coli cells, and then sending $50 isolated clones for automated DNA sequencing. Three rats or mice were used for each group of animals. A total of 150 clones were screened to determine RNA editing for each brain or spinal cord region. To compare peak heights of the chromatogram bases, the peak height of guanosine was divided by the combined peak heights of adenosine and guanosine bases to estimate the percent of RNA editing.
Construction of Rat Full-Length Ca V 1.3 with Edited IQ Motif
The first four amino acids of the Ca V 1.3 consensus IQ motif is IQDY corresponding to nucleotide sequence ATACAGGACTAC. We generated six edited Ca V 1.3 a 1D subunits from the reference wild-type a 1D-IQfull channels (Shen et al., 2006) , now designated a 1D-IQDY. The edited subunits were named a 1D-MQDY , a 1D-IRDY , a 1D-MRDY , a 1D-IQDC , a 1D-MQDC , and a 1D-MRDC . The a 1D-MQDY , a 1D-MQDC , a 1D-IQDC , and a 1D-IQDC edited clones were generated by replacing a BstEII/NotI RT-PCR fragment containing the respective edited sites into the reference clone. The other edited clones were generated by in vitro mutagenesis using the following primers set 5 Whole-Cell Patch-Clamp Electrophysiology HEK293 cells were transiently transfected with a 1D-IQDY , a 1D-MQDY , a 1D-IRDY , and a 1D-MRDY (1.25 mg) and rat b 2a (1.25 mg) and a 2 d (1.25 mg), using the standard calcium phosphate transfection methods (Tang et al., 2004) . The b 2a and a 2 d clones were kindly provided by Dr. Terry Snutch (University of British Columbia). Electrophysiological recordings were performed as reported previously (Evans and Zamponi, 2006; Yang et al., 2006) , and details are found in Supplemental Information (section 6). mice (Higuchi et al., 2000) were maintained on a 12 hr light/dark cycle using normal fluorescent room light. Coronal brain slices (250 mm thick) containing suprachiasmatic nucleus were obtained from 5-to 8-week-old mice anesthetized with isoflurane and decapitated. All experimental procedures were in accordance with the animal welfare guidelines of the Max-Planck-Society. The slicing chamber contained an oxygenated ice-cold solution composed of (in mM): NaCl, 125; KCl, 2.5; NaH 2 PO 4 , 1.25; NaHCO 3 , 25; MgCl 2 $6H 2 O, 1.0; myo-Inositol, 3; Na-pyruvate, 2; vitamin C, 0.4; CaCl 2 , 1; MgCl 2 , 5; and glucose, 25. Slices were incubated for 30 min at 30 C before being stored at room temperature in artificial CSF (ACSF) containing (in mM): NaCl, 125; NaHCO 3 , 25; KCl, 2.5; NaH 2 PO4, 1.25; MgCl 2 , 1; CaCl 2 , 2; and glucose, 25; bubbled with 95% O 2 and 5% CO 2 .
SCN Slice Preparation

Whole-Cell Recording in SCN Slices
Current-clamp recording were made using EPC-9 amplifier controlled by Patchmaster (Heka Elektronik, Lambrecht, Germany). Patch pipettes were pulled from borosilicate glass capillaries and had resistances of 4-6 MU when filled with (in mM): K-gluconate, 130; K-Cl, 10.00; EGTA, 5; N-(2-hydroxyethyl) piperazine-N 0 -ethanesulfonic acid (HEPES); Na 3 GTP, 0.5; MgATP, 4.0;
and Na-Phosphocreatine, 10.0. Brain slices were mounted on upright fixed stage microscope equipped with 403 water immersion lens and constantly perfused with the above mentioned oxygenated ACSF at a flow rate of 1.5 to 2 ml/min at room temperature. The SCN was identified as a bilaterally symmetrical, cell dense region superior to the optic chiasm and lateral to the inferior apex of the third ventricle (Pennartz et al., 1998) . Individual SCN neurons were identified by IR-DIC camera. Only cells in the dorsal medial shell were patched where cluster I SCN neurons are dominant (Paxinos and Franklin, 2001 ). The cluster I neurons were identified by their steeply rising and monophasic AHP (Pennartz et al., 1998) . After formation of giga seal (>3 GU) formation, input resistance was monitored regularly by measuring voltage response by a À20 pA current injection. The reported membrane potential was corrected for the liquid junction potential À14.5mV. For voltage-clamp recording of SCN neurons, the external solution used contained 10 mM HEPES, 140 mM tetraethylammonium methanesulfonate, and 10 mM BaCl 2 or CaCl 2 (pH was adjusted to 7.4 with CsOH and osmolarity to 290-310 mOsm with glucose). The external solution was constantly bubbled with 95% O 2 and 5% CO 2 . The internal solution (pipet solution) contained 130 mM Cs-MeSO 3 , 5 mM CsCl, 5 mM EGTA, 10 mM HEPES, 1 mM MgCl 2 , 2 mg/ml Mg-ATP, pH 7.3 (adjusted with CsOH). The osmolarities of solutions used were adjusted to between 290 and 300 mOsm with glucose. A junction potential of À11mV was uncorrected for, and true voltage may be obtained by subtracting 11mV from the reported values.
Drug Preparation
Stock solutions were prepared by dissolving nimodipine (RBI) in 100% ethanol and TTX (Alomone Labs) in distilled water. The solutions were subsequently diluted in ACSF to respective final concentrations. Nimodipine was protected from light during these procedures.
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